摘要
蛇是迷人的生物,在古代人类居住在地球之前,已经是这个星球的居民。毒蛇一直是恐惧的数字,并在全世界造成显着的死亡。毒液构成了具有各种异构体的蛋白质和肽的家族,使其成为不同分子的混合物。这些生物分子是造成受害者基本生理系统紊乱的原因,导致发病,如果不治疗,可导致死亡。研究人员通过技术进步将这些危及生命的毒素转化为拯救生命的治疗药物。由于卡托普利的发展,第一种衍生自黄芪的缓激肽增效肽的药物,对某些类型的癌症具有强力活性的解毒素,蛇毒组分对于新药的铅化合物的发展具有很大的潜力。蛇毒新药从凝血病和止血到抗癌药物的不断发展。在这次审查中,我们专注于临床使用或发展阶段的不同蛇毒蛋白
关键词: 蛇毒素,治疗剂,毒液诊断工具,抗凝剂,药物发现和开发,肽药物,制药工业,纤维蛋白密封剂,奥米科技。
Current Medicinal Chemistry
Title:Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Volume: 24 Issue: 17
关键词: 蛇毒素,治疗剂,毒液诊断工具,抗凝剂,药物发现和开发,肽药物,制药工业,纤维蛋白密封剂,奥米科技。
摘要: Snakes are fascinating creatures and have been residents of this planet well before ancient humans dwelled the earth. Venomous snakes have been a figure of fear, and cause notable mortality throughout the world. The venom constitutes families of proteins and peptides with various isoforms that make it a cocktail of diverse molecules. These biomolecules are responsible for the disturbance in fundamental physiological systems of the envenomed victim, leading to morbidity which can lead to death if left untreated. Researchers have turned these life-threatening toxins into life-saving therapeutics via technological advancements. Since the development of captopril, the first drug that was derived from bradykininpotentiating peptide of Bothrops jararaca, to the disintegrins that have potent activity against certain types of cancers, snake venom components have shown great potential for the development of lead compounds for new drugs. There is a continuous development of new drugs from snake venom for coagulopathy and hemostasis to anti-cancer agents. In this review, we have focused on different snake venom proteins / peptides derived drugs that are in clinical use or in developmental stages till to date. Also, some commonly used snake venom derived diagnostic tools along with the recent updates in this exciting field are discussed.
Export Options
About this article
Cite this article as:
Snake Venom: From Deadly Toxins to Life-saving Therapeutics, Current Medicinal Chemistry 2017; 24 (17) . https://dx.doi.org/10.2174/0929867324666170605091546
DOI https://dx.doi.org/10.2174/0929867324666170605091546 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy
and Cardiovascular Autonomic Neuropathy
Current Diabetes Reviews Spermine Metabolism and Anticancer Therapy
Current Cancer Drug Targets Pulmonary Hypertension in the Critically Ill
Current Hypertension Reviews A Systematic Review of Randomized Controlled Trials Examining the Nephroprotective Properties of Antihypertensive Medications
Current Hypertension Reviews Levosimendan for Heart-Operated Patients: What is the State of the Art?
Recent Patents on Cardiovascular Drug Discovery Intestinal Barrier Dysfunction in Human Pathology and Aging
Current Pharmaceutical Design Endoplasmic Reticulum Stress and Atherosclerosis
Current Hypertension Reviews Long-Acting Antipsychotic Medications
Current Drug Targets Current Role and Future Perspectives of Radioiodinated MIBG in the Evaluation of Dementia with Lewy Bodies
Current Radiopharmaceuticals Prodrugs in Photodynamic Anticancer Therapy
Current Pharmaceutical Design Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
Current Pharmaceutical Design Citric Acid: A Green Bioorganic Catalyst for One-Pot Three-Component Synthesis of 2,3-dihydroquinazoline-4 (1H)-ones
Current Organocatalysis Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Editorial(Angiotensin II Receptor Research)
Current Pharmaceutical Design Psychopharmacological Interventions for Adolescents with Eating Disorders
Adolescent Psychiatry Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
Current Pharmaceutical Design Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety